Company: APM
Filing Date: 2025-07-22
Form Type: 6-K
Source: 0001213900-25-066642
Chunk: 2

Company: Aptorum Group Ltd
Filing Date: 2025-07-22
Form: 6-K
Chunk 2
---
 services DiamiR‘s CLIA/CAP-certified laboratory offers protein and genetic biomarker analysesfor screening, patient stratification, disease and treatment monitoring.

<div align='center'>1</div>

Merger Consideration

At the Effective Time, each
then-outstanding share of DiamiR’s common stock, other than dissenting shares, will be converted into a number of shares of Aptorum
Delaware common stock, to the extent that, immediately following the closing of the Merger, stockholders of DiamiR and existing Aptorum’s
shareholders will own approximately 70% and 30%, respectively, of the outstanding shares of the Combined Company.

Representations and Warranties in the Merger Agreement

The Merger Agreement contains customary representations and warranties
of the parties thereto with respect to, among other things, the following as applicable to each party: (i) due authorization; (ii) no
conflicts; (iii) governmental authorities and consents; (iv) capitalization; (v) financial statements and absence of changes; (vi) undisclosed
liabilities; (vii) litigation and proceedings; (viii) compliance with laws; (ix) contracts and no defaults; (x) labor matters; (xi) tax
matters; (xii) real property; (xiii) intellectual property, privacy and data security; (xiv) brokers’ fees; (xv) related party transactions;
(xvi) information supplied; (xvii) insurance; (xviii) U.S. business; and (xix) absence of a material adverse effect.

Covenants in the Merger Agreement

Each of Aptorum and DiamiR
has agreed to certain covenants in the Merger Agreement governing the conduct of its respective business between the date of the Merger
Agreement and the Closing or the earlier termination of the Merger Agreement. In general, from the date of the Merger Agreement until
the earlier of the Closing and the termination of the Merger Agreement, except as required by applicable law, as set forth in the Merger
Agreement or other transaction documents, each party must and must cause each of its subsidiaries to conduct its business in the ordinary
course of business in all material respects.

In addition, except as otherwise
specifically contemplated by the Merger Agreement, disclosure schedules, or other transaction documents, as may be required by law, or
unless the otherwise consented by Aptorum in writing,